Sanofi-Aventis Says K&L Gates Can Be Sanctioned In FCA Suit
By Diana Novak Jones ( November 13, 2015, 3:43 PM EST) -- Sanofi-Aventis told a California federal judge that he should sanction generic-drug maker Amphastar and its K&L Gates LLP counsel after the judge found that notebooks Amphastar submitted as evidence that it had developed a generic version of Sanofi's anti-clotting drug on its own had been doctored....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.